Clicky

MorphoSys AG(MOR)

Description: MorphoSys AG engages in the development of therapeutic antibodies to cure inflammatory and autoimmune diseases, as well as cancer and infectious diseases. The company operates through two business segments; Partnered Discovery and Proprietary Development.


Keywords: Cancer Infectious Diseases Immunology Antibodies Autoimmune Disease Antibody Autoimmunity Evotec Inflammatory And Autoimmune Diseases Morphosys

Home Page: www.morphosys.com

MOR Technical Analysis

Semmelweisstrasse 7
Planegg, 82152
Germany
Phone: 49 89 89927 0


Officers

Name Title
Dr. Jean-Paul Kress M.D. Chairman of Management Board, MD & CEO
Mr. Sung H. Lee CFO & Member of Management Board
Dr. Marlies Sproll Special Adviser to the Chief Exec. Officer
Mr. Klaus De Wall Head of Accounting & Tax
Ms. Lara Smith Weber Head of Controlling, Corp. Fin. & Corp. Devel.
Dr. Margit Urban Head of Discovery Alliances & Technologies
Dr. Anja Pomrehn Sr. VP & Head of Investor Relations
Ms. Charlotte Lohmann Sr. VP of Legal, Compliance & IP and Gen. Counsel
Mr. Thomas Biegi VP & Head of Corp. Communications
Ms. Maria Castresana Sr. VP & Global Head of HR

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 322.5806
Trailing PE: 0
Price-to-Book MRQ: 5.409
Price-to-Sales TTM: 2.1842
IPO Date: 1999-03-09
Fiscal Year End: December
Full Time Employees: 627
Back to stocks